DSM Venturing Corporate VC of DS M DS M Venturing Corporate VC - - PowerPoint PPT Presentation

▶
dsm venturing
SMART_READER_LITE
LIVE PREVIEW

DSM Venturing Corporate VC of DS M DS M Venturing Corporate VC - - PowerPoint PPT Presentation

Oct 14, 2023 502 likes •660 views

Thi s im DSM Venturing Corporate VC of DS M DS M Venturing Corporate VC of DS M DSM company profile DS M is a global science-based company active in health, nut rition and materials. By connecting our unique competences in Life S

slide-1
SLIDE 1 Thi s im

DSM Venturing

Corporate VC of DS M

slide-2
SLIDE 2

DSM company profile

DS M is a global science-based company active in health, nut rition and

  • materials. By connecting our unique competences in Life S

ciences and Materials S ciences we are driving economic prosperity, environmental progress and social advances t o create sustainable value for all stakeholders. We deliver innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceut icals, medical devices, automot ive, paints, elect rical and elect ronics, life protect ion, alternative energy and bio-based materials. DS M has annual net sales of around € 9 billion. Our company is headquartered in the Netherlands, and we employ approximately 22,000 people across the globe.

Page 1

DS M Venturing – Corporate VC of DS M

slide-3
SLIDE 3

DSM in motion: driving focused growth

Page 2

People - Planet - Profit: creating value along three dimensions

DS M Venturing – Corporate VC of DS M

slide-4
SLIDE 4

Innovation boost 2005 - 2010

Proud to have achieved

  • € 1bn sales from innovation
  • Increased speed of innovation
  • S

ett ing up EBAs

  • S

trong innovation infrastructure/ culture

  • External recognition as leading innovator

Page 3

DS M Venturing – Corporate VC of DS M

Proven our ability to accelerate the pace of innovation

slide-5
SLIDE 5

Innovation in new strategy

Next level aspiration

  • Innovation sales: > 20%
  • f t otal sales
  • Sales EBAs (BMM/ BP&S): > € 1bn
  • Innovation focus on platforms
  • Value creat ion via best practices
  • S

et up China and India Innovation Centers

Page 4

From 12% to 20%

Innovation sales

DS M Venturing – Corporate VC of DS M

Doubling innovation sales

slide-6
SLIDE 6

Focused platforms and a well-stocked pipeline

Page 5

DS M Venturing – Corporate VC of DS M

Emerging Business Areas ( DSM Innovation Center)

Climate & Energy Health & Wellness Global shifts

(Bio) Manufacturing Bio-based clean / green materials Sports & Life Protection Materials Food/feed ingredients

Innovation Platforms (Examples - Business Groups)

Bio processing ingredients

Biomedical Advanced Surfaces Bio-based Products & Services

slide-7
SLIDE 7

Accelerating and supporting innovation

EBA Biomedical EBA Advanced S urfaces EBA Bio-based Products & S ervices CTO Office Business Incubator Venturing

DSM Innovation Center New Business Development

Excellence in Innovation Licensing

Page 6

DS M Venturing – Corporate VC of DS M

Enablers

slide-8
SLIDE 8

DSM Venturing - Mission

DSM´s competence center for external (VC) participations aimed at boosting innovation & growth

Window to the world Explore new emerging markets, technologies and products in order to enhance DS M´s product port folio, technology toolbox and business model's Strategic value Add value int ernally and ext ernally t hrough facilitating strategic co-

  • perations with start-ups

Financial return Create value by investing in and divesting start-up companies

Page 7

DS M Venturing – Corporate VC of DS M

slide-9
SLIDE 9

When does DSM Venturing invest?

DS M Venturing – Corporate VC of DS M

Page 8

High Low Low High Emerging Technology Proof of principle Commercializat ion Expansion Time Venture Capital Public/ PE Grants "Angels"

Sales Investment & Risk Financing gap

Risk Investment amount s S ales

DSM Venturing

slide-10
SLIDE 10

Summary Investment scope

  • Companies in early st age to expansion stage, act ive in DSM strategic scope
  • Typical initial investment: € 0.5 – 5 mln
  • Minorit y part icipat ions typically a 10 - 25%

stake

  • Recognized pot ent ial for strat egic cooperation wit h DS

M Businesses

  • Represent ation in board of start-up
  • Global (focus on US

A, EU)

DS M Venturing – Corporate VC of DS M

Page 9

slide-11
SLIDE 11

Track Record

  • 40 direct investments since 2001; 23 st ill active in our current portfolio
  • 17 divested:

– 2 acquired by DS M businesses (LTP and TCG) – 2 sold to third party acquirers (Morphotek and OPM) – 2 sold back to the founders (Creagri and Terreco) – 1 successful IPO (S peedel) – 10 failed and were dissolved, liquidated, wound down

  • Net financial result is positive – i.e. ‘ free’ option generation!
  • Part nerships realized with 30 port folio companies in various forms and

degrees (feasibility studies, j oint development, licensing, distribut ion/ marketing relations, supply relations)

  • In addition, DS

M Venturing facilitated similar partnerships with > 50 other start-ups which it scouted but did not invest in

  • We scouted and screened more than 3000 companies which provided

useful insights and complementary window-on-the-world for our businesses

DS M Venturing – Corporate VC of DS M

Page 10

slide-12
SLIDE 12 Thi s im

Portfolio Direct Investments

Life Sciences Material Sciences

slide-13
SLIDE 13

Venturing team

Page 12 Marcel Kloosterman Invest ment Manager IanFreelance S enior Investment Manager EU Casper Bruens S enior Investment Manager Greg McParland S enior Investment Manager US A Pieter Wolters Managing Direct or

For personal use only

slide-14
SLIDE 14